Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lupin Adds To US Portfolio

With Launch Of Doxercalciferol

Jan 02 2020

• By Vibha Ravi

SC1804_Medical Biz_621316742 _1200.jpg — Lupin Adds Products To US Portfolio • Source: Shutterstock

Related Content

Lupin Q1 Profit Up 50% But Regulatory Overhang, Slow Product Scale-Up Sparks Concern

Aug 13 2019

Lupin-Aptar Launch India’s First Smart Device For MDIs At $22 Apiece

Nov 27 2019

Related Companies

Lupin Limited

Sanofi

Sun Pharmaceutical Industries Ltd.

Novartis AG

Hospira, Inc.

Hikma Pharmaceuticals plc

Amneal Pharmaceuticals, Inc.

Akorn, Inc.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Novartis AG

Viatris Inc.

Teva Pharmaceutical Industries Ltd.

Accord Healthcare Ltd.

Merck & Co., Inc.

Taro Pharmaceutical Industries Ltd.

Teligent, Inc.

Additional Topics

United States India Asia Pacific Launches Generic Drugs BioPharmaceutical

More from Products

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.